CorMedix CRMD Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total selling and marketing expense by Business | ||||||
| Employee and contracted employee expense | $7.3M— | —— | $7.32M+129% | $3.19M+54.7% | $2.06M— | |
| Other selling and marketing | $5.23M-12.4% | $5.97M+54.7% | $3.86M+21.0% | $3.19M+32.4% | $2.41M-33.9% | |
| Total research and development by Business | ||||||
| Employee and contracted employee expense | $2.34M— | —— | —— | —— | $1.1M— | |
| Other research and development | $4.87M-8.5% | $5.33M+78.3% | $2.99M+154% | $1.17M-43.9% | $2.09M+122% | |
| Total general and administrative expense by Business | ||||||
| Employee and contracted employee expense | $10.53M— | —— | —— | —— | $6.84M— | |
| Other general and administrative | $11.19M-20.1% | $14.02M-7.4% | $15.14M+317% | $3.63M+27.3% | $2.85M-7.3% | |
| Total Revenue by Product | ||||||
| Contract revenue | $5.51M+18.9% | $4.64M+69.9% | $2.73M— | $0— | $0— | |
| DefenCath | $97.51M— | —— | —— | —— | $39.08M+260% | |
| Melinta Portfolio | $24.41M— | —— | —— | —— | $0— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does CorMedix break its business down?
- CorMedix (CRMD) reports total selling and marketing expense by business across 2 parts — Employee and contracted employee expense and Other selling and marketing. Each is extracted from the segment footnotes and tracked over time.
- Where does CorMedix's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in CorMedix's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
